Platelets as initiators and mediators of inflammation at the vessel wall
- PMID: 21094986
- PMCID: PMC3068230
- DOI: 10.1016/j.thromres.2010.10.019
Platelets as initiators and mediators of inflammation at the vessel wall
Abstract
Platelets are dynamic cells with activities that extend beyond thrombosis including an important role in initiating and sustaining vascular inflammation. A role for platelets has been described in many physiologic and pathophysiologic processes such as atherosclerosis, stem cell trafficking, tumor metastasis, and arthritis. Platelet activation at sites of an intact inflamed endothelium contributes to vascular inflammation and vascular wall remodeling. Platelets secrete a wide array of preformed and synthesized inflammatory mediators upon activation that can exert significant local and systemic effects. This review will focus on the role of platelet derived mediators in vascular inflammation and vascular wall remodeling.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Platelets and platelet-derived microparticles in vascular inflammatory disease.Inflamm Allergy Drug Targets. 2010 Dec;9(5):346-54. doi: 10.2174/187152810793938008. Inflamm Allergy Drug Targets. 2010. PMID: 21054257 Review.
-
Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis.Platelets. 2013;24(4):255-62. doi: 10.3109/09537104.2012.690113. Epub 2012 Jun 6. Platelets. 2013. PMID: 22671308 Review.
-
[Role of platelets in atherosclerosis and inflammation].Med Klin (Munich). 2006 Jun 15;101(6):467-75. doi: 10.1007/s00063-006-1066-0. Med Klin (Munich). 2006. PMID: 16767570 Review. German.
-
Platelet dysfunction in vascular pathologies and how can it be treated.Thromb Res. 2012 Feb;129(2):116-26. doi: 10.1016/j.thromres.2011.09.026. Epub 2011 Oct 27. Thromb Res. 2012. PMID: 22035630 Review.
-
Platelets in the onset of atherosclerosis.Blood Cells Mol Dis. 2006 Mar-Apr;36(2):206-10. doi: 10.1016/j.bcmd.2005.12.022. Epub 2006 Feb 13. Blood Cells Mol Dis. 2006. PMID: 16476558 Review.
Cited by
-
Platelets as cellular effectors of inflammation in vascular diseases.Circ Res. 2013 May 24;112(11):1506-19. doi: 10.1161/CIRCRESAHA.113.300512. Circ Res. 2013. PMID: 23704217 Free PMC article. Review.
-
Gut Microbiota-Related Effects of Tanhuo Decoction in Acute Ischemic Stroke.Oxid Med Cell Longev. 2021 May 27;2021:5596924. doi: 10.1155/2021/5596924. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34136066 Free PMC article.
-
Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals.J Thromb Thrombolysis. 2015 Nov;40(4):458-67. doi: 10.1007/s11239-015-1212-8. J Thromb Thrombolysis. 2015. PMID: 25899563 Clinical Trial.
-
Editorial: Role of the Platelet Phenomenon in Cardiovascular Diseases and Cancer.Front Cardiovasc Med. 2022 Mar 23;9:859770. doi: 10.3389/fcvm.2022.859770. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35402555 Free PMC article. No abstract available.
-
Relationships of handgrip strength with the presence of cerebral microbleeds and platelet count in older Japanese adults.Oncotarget. 2020 May 12;11(19):1705-1713. doi: 10.18632/oncotarget.27573. eCollection 2020 May 12. Oncotarget. 2020. PMID: 32477460 Free PMC article.
References
-
- Morrell CN, Murata K, Swaim AM, Mason E, Martin TV, Thompson LE, et al. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ Res. 2008 Apr 11;102(7):777–785. - PubMed
-
- Sachais BS, Turrentine T, Dawicki McKenna JM, Rux AH, Rader D, Kowalska MA. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE−/− mice. Thromb Haemost. 2007 Nov;98(5):1108–1113. - PubMed
-
- Bracco M, Curti PC. The vasoconstrictor factor of platelets. Experientia. 1954 Feb 15;10(2):71–72. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical